Scientists develop nanoantidotes to reduce acidosis in critically ill patients with COVID-19
A group of scientists in China has recently developed an antacid nanoantidote that can effectively improve blood acidosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study has been published in the journal VIEW. Study: Nanoantidote for pH Suppression of Acidosis Promoting COVID-19 Infection. Image credit: ANDREI ASKIRKA/Shutterstock background Coronavirus disease 2019 …